Abstract 549: Immune profiling uncovers neo-antigens and TCR repertoire responding to WX-mPD-1 and WX-mPD-L1 immune checkpoint inhibitors in syngeneic mouse xenograft models

Checkpoint Inhibitors ◽

Mouse Xenograft ◽

Syngeneic Mouse ◽

Tcr Repertoire ◽

Xenograft Models ◽

Immune Profiling

Abstract A6: RNAseq and immune profiling analysis of syngeneic mouse models treated with immune checkpoint inhibitors enable biomarker discovery and model selection for cancer immunotherapy

10.1158/1535-7163.targ-15-a6 ◽

2015 ◽

Cited By ~ 1

Author(s):

Lan Zhang ◽

Juan Zhang ◽

Qian Shi

Keyword(s):

Model Selection ◽

Mouse Models ◽

Immune Checkpoint ◽

Biomarker Discovery ◽

Checkpoint Inhibitors ◽

Syngeneic Mouse ◽

Selection For ◽

Immune Profiling ◽

Profiling Analysis

Immunophenotyping, RNAseq, microbiota analysis of syngeneic mouse models treated with immune checkpoint inhibitors to support biomarker and immune-oncology drug discovery

European Journal of Cancer ◽

10.1016/s0959-8049(16)32919-7 ◽

2016 ◽

Vol 69 ◽

pp. S108

Author(s):

L. Zhang ◽

M. Qiao ◽

J. Zhang ◽

S. Guo ◽

W. Qian ◽

...

Keyword(s):

Drug Discovery ◽

Mouse Models ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Syngeneic Mouse ◽

Oncology Drug ◽

Microbiota Analysis ◽

Immune Oncology

Abstract 5177: RNAseq and FACS profiling of syngeneic mouse models treated with immune checkpoint inhibitors enable biomarker discovery and model selection for cancer immunotherapy

10.1158/1538-7445.am2016-5177 ◽

2016 ◽

Author(s):

Lan Zhang ◽

Juan Zhang ◽

Sheng Guo ◽

Wubin Qian ◽

Zhensheng Wang ◽

...

Keyword(s):

Model Selection ◽

Cancer Immunotherapy ◽

Mouse Models ◽

Immune Checkpoint ◽

Biomarker Discovery ◽

Checkpoint Inhibitors ◽

Syngeneic Mouse ◽

Selection For

Abstract 5130: Immune profiling of malignant effusion from metastatic gastric cancer patients as a predictive biomarker for immune checkpoint inhibitors

10.1158/1538-7445.am2016-5130 ◽

2016 ◽

Author(s):

Woo Sun Kwon ◽

So Jung Lim ◽

Won Suk Lee ◽

Eunji Jo ◽

Hyun-jeong Kim ◽

...

Keyword(s):

Gastric Cancer ◽

Cancer Patients ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Predictive Biomarker ◽

Metastatic Gastric Cancer ◽

Malignant Effusion ◽

Gastric Cancer Patients ◽

Immune Profiling

Systemic leukocyte delivery of oncolytic myxoma virus armed with tumor necrosis factor combines with immune checkpoint inhibitors to eliminate lung metastatic syngeneic mouse osteosarcoma.

Molecular Therapy — Oncolytics ◽

10.1016/j.omto.2021.07.014 ◽

2021 ◽

Author(s):

John D. Christie ◽

Nicole Appel ◽

Hannah Canter ◽

Jazmin Galvan Achi ◽

Natalie M. Elliott ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Immune Checkpoint ◽

Tumor Necrosis ◽

Checkpoint Inhibitors ◽

Myxoma Virus ◽

Syngeneic Mouse ◽

Necrosis Factor

Abstract #827: Panhypopituitarism Due to Immune Checkpoint Inhibitors

Endocrine Practice ◽

10.1016/s1530-891x(20)44572-0 ◽

2017 ◽

Vol 23 ◽

pp. 176-177

Author(s):

Kaitlyn Steffensmeier ◽

Bahar Cheema ◽

Ankur Gupta

Keyword(s):

Immune Checkpoint ◽

Abstract #582 Endocrine Consequences of Combination Therapy of Immune Checkpoint Inhibitors in Cancer Patients

Endocrine Practice ◽

10.1016/s1530-891x(20)46926-5 ◽

2019 ◽

Vol 25 ◽

pp. 297-298

Author(s):

Sevil Aliyeva ◽

Pamela Schroeder ◽

Issam Cheikh

Keyword(s):

Combination Therapy ◽

Cancer Patients ◽

Immune Checkpoint ◽

Decision letter for "Hematological toxicities in immune checkpoint inhibitors: a pharmacovigilance study from 2014 to 2019"

10.1002/hon.2743/v1/decision1 ◽

2019 ◽

Keyword(s):

Immune Checkpoint ◽

A systematic review and meta-analysis of endocrine-related adverse events associated with immune checkpoint inhibitors

Endocrine Abstracts ◽

10.1530/endoabs.56.gp211 ◽

2018 ◽

Author(s):

Filette Jeroen de ◽

Corina Andreescu ◽

Filip Cools ◽

Bert Bravenboer ◽

Brigitte Velkeniers

Keyword(s):

Systematic Review ◽

Adverse Events ◽

Immune Checkpoint ◽

Checkpoint Inhibitors ◽

Meta Analysis

A Case of Malignant Melanoma Associated with Polymyositis Treated with Immune Checkpoint Inhibitors

Nishi Nihon Hifuka ◽

10.2336/nishinihonhifu.81.396 ◽

2019 ◽

Vol 81 (5) ◽

pp. 396-400 ◽

Cited By ~ 1

Author(s):

Hayato NOMURA ◽

Osamu YAMASAKI ◽

Tatsuya KAJI ◽

Hiroshi WAKABAYASHI ◽

Yoshia MIYAWAKI ◽

...

Keyword(s):

Malignant Melanoma ◽

Immune Checkpoint ◽